tenk.fyi

Neumora Therapeutics, Inc.

NMRANasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

-

Net Income

-$243.8M

3.3% YoY

EPS

$-1.53

57.9% YoY

Cash

$142.1M

62.0% YoY

FY 2024 · As of 2024-12-31